Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Brain tumor surgeries are among the most challenging procedures in neurosurgery, necessitating careful anesthetic management to achieve maximal tumor resection while preserving neurological function. Anesthesia affects key physiological parameters, including cerebral blood flow, intracranial pressure, and blood-brain barrier permeability, which are crucial in determining surgical outcomes. This mini-review examines the effects of various anesthetic agents, such as propofol, isoflurane, and sevoflurane, on tumor perfusion and infiltration, highlighting their potential to modulate tumor biology through mechanisms involving immune response, angiogenesis, and molecular pathways. The mini-review identifies critical gaps in the literature, particularly concerning the long-term impacts of anesthetic agents on tumor biology and patient survival, and calls for well-conducted randomized controlled trials to address these issues. Furthermore, it explores innovative strategies, including targeted anesthesia delivery and the integration of genomic and proteomic data, to enhance personalized patient care. By synthesizing current knowledge and identifying areas for future research, this mini-review aims to provide a foundation for optimizing anesthetic protocols in brain tumor surgeries to improve both short- and long-term patient outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369764PMC
http://dx.doi.org/10.1097/MS9.0000000000003454DOI Listing

Publication Analysis

Top Keywords

brain tumor
12
tumor
8
tumor perfusion
8
perfusion infiltration
8
tumor surgeries
8
anesthetic agents
8
tumor biology
8
effects anesthesia
4
anesthesia tumor
4
infiltration brain
4

Similar Publications

Early postoperative seizures, defined as occurring within 7 days after surgery, are a significant complication that occurs following neurosurgical procedures involving cerebral manipulation. As a result, short-term antiseizure medication is typically administered in Japan despite the lack of consensus regarding its prophylactic use. Perampanel hydrate, an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, was recently introduced in an intravenous formulation in Japan, providing new potential for early postoperative seizures prevention during the perioperative period.

View Article and Find Full Text PDF

Glioblastoma (GB), IDH-wildtype (IDH-wt), is the most prevalent primary malignant brain neoplasm in adults. Despite adjuvant therapy, the prognosis for these tumors remains dismal, with a median survival of around 15-18 months. Although rare, extracranial metastases from GB are reported with increasing frequency, likely due to advancements in follow-up, treatments, and improved patient survival.

View Article and Find Full Text PDF

One of the key factors contributing to the poor prognosis of glioblastoma is the treatment resistance of glioma stem cells (GSCs). In this study, the efficacy of photodynamic therapy (PDT) using talaporfin sodium (NPe6), a second-generation photosensitizer, in combination with a semiconductor laser approved for clinical use in Japan was evaluated. The evaluation was performed in a patient-derived glioma stem cell (GSC) line, MGG8, which was established from human glioblastoma tissue.

View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is a rapidly progressing brain malignancy, with its progression closely tied to a hypoxic microenvironment. Hypoxia-inducible factor-1α (HIF-1α) acts as a vital regulator in tumor adaptation to low oxygen levels, and its relationship with the Wnt/β-catenin signaling pathway exerts significant functions in the malignant properties of GBM. In this research, Western blot and qRT-PCR were applied to check β-catenin and HIF-1α expression in GBM.

View Article and Find Full Text PDF

Diagnostic Value of Centrally Restricted Diffusion in Differentiating Radiation Necrosis from Tumor Progression in Brain Metastases: A Single-Center Observational Study.

J Neuroradiol

September 2025

Department of Neuroradiology, East Group Hospital, Hospices Civils de Lyon. 59 Bd Pinel, 69500, Bron, France; CREATIS Laboratory, CNRS UMR 5220, INSERM U1294, Claude Bernard Lyon I University. 7 avenue Jean Capelle O, 69100, Villeurbanne, France. Electronic address:

Background: Distinguishing radiation necrosis (RN) from true progression (TP) in irradiated brain metastases is challenging. We evaluated the diagnostic performance of the centrally restricted diffusion sign on diffusion-weighted imaging (DWI).

Methods: From August 2014 to August 2024, we screened 321 patients with histologically confirmed brain metastases treated with radiation therapy and follow-up MRI for new or enlarging necrotic lesions ≥1 cm.

View Article and Find Full Text PDF